Delcath taps Miao as CFO

Delcath Systems  ($DCTH) has named Graham Miao as CFO. David McDonald, who has served as the company's CFO since 2009, will assume the newly created role of executive VP, business development.

Miao joins Delcath from Dun & Bradstreet Corporation, where he served as chief of staff of the Global CFO Organization. Previously, he held the position of executive VP & CFO of Pagoda Pharmaceuticals, a Shanghai-based specialty pharmaceuticals and medical device company focused in urology and allergies. In addition, Miao held positions at Schering-Plough, Pharmacia and J.P. Morgan.

"The timing of Graham Miao's appointment as CFO is part of the planned expansion of our executive leadership team in advance of the expected commercial launch of our Hepatic CHEMOSAT Delivery System at the end of this year," CEO Eamonn Hobbs explained in a statement. "His knowledge of the global pharmaceutical industry landscape and experience in both established and development stage pharmaceutical/medical device companies will bring additional strategic insights as well."

- check out the Delcath announcement

Suggested Articles

The FDA has approved its first contact lens designed to effectively slow the progression of nearsightedness in children, starting in ages 8 to 12.

Novartis tapped Biofourmis to develop tracking programs for heart failure patients, as the latter acquired Biovotion, makers of clinical wearables.

Janssen is planning its first completely virtual clinical trial, using personal smartphones and wearable devices with no in-person site visits.